| Original language | English (US) |
|---|---|
| Pages (from-to) | 1159-1162 |
| Number of pages | 4 |
| Journal | Journal of Allergy and Clinical Immunology |
| Volume | 129 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2012 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy. / Kulis, Michael; Saba, Katie; Kim, Edwin H.; Bird, J. Andrew; Kamilaris, Nikolas; Vickery, Brian P.; Staats, Herman; Burks, A. Wesley.
In: Journal of Allergy and Clinical Immunology, Vol. 129, No. 4, 04.2012, p. 1159-1162.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy
AU - Kulis, Michael
AU - Saba, Katie
AU - Kim, Edwin H.
AU - Bird, J. Andrew
AU - Kamilaris, Nikolas
AU - Vickery, Brian P.
AU - Staats, Herman
AU - Burks, A. Wesley
N1 - Funding Information: Supported by National Institutes of Health (NCCAM) grant R01-AT004435-04 . Funding Information: Disclosure of potential conflict of interest: M. Kulis has received research support from the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) fellowship . J. A. Bird is a speaker for Nutricia and has received research support from the American Academy of Allergy, Asthma & Immunology (AAAAI)/Food Allergy Initiative (FAI) Howard Gittis Memorial Fellowship Award . B. P. Vickery has received research support from the NIH/NIAID and the Thrasher Research Fund . A. W. Burks is a minority stockholder in Allertein and Mast Cell, Inc; is on the advisory board for Dannon Co Probiotics; is a consultant for Exploramed Development LLC, Intelliject, McNeil Nutritionals, Merck, Novartis, Pfizer, Portola Pharmaceuticals Inv, and Schering-Plough; is on the Nutricia Expert Panel; has received research support from the NIH, Food Allergy and Anaphylaxis Network (FAAN), FAI, National Peanut Board, Scientific Hospital Supplies, and Wallace Research Foundation ; has provided legal consultation/expert witness testimony on the topic of food allergy; is on the FAAN Medical Board of Directors; is an American College of Allergy, Asthma & Immunology Dermatological Allergy Committee Member; is an NIH/Human-Animal Interaction Study Section Member; and is on the Journal of Allergy and Clinical Immunology and US Food and Drug Administration Reviewer Boards. The rest of the authors declare that they have no relevant conflicts of interest.
PY - 2012/4
Y1 - 2012/4
UR - http://www.scopus.com/inward/record.url?scp=84859161585&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84859161585&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2011.11.045
DO - 10.1016/j.jaci.2011.11.045
M3 - Article
C2 - 22236732
AN - SCOPUS:84859161585
VL - 129
SP - 1159
EP - 1162
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
SN - 0091-6749
IS - 4
ER -